About US
Contact us
-
GSK, Pfizer go for radical makeovers with giant consumer combo destined for spinoffTurns out, after GlaxoSmithKline walked away from a chance to scoop up Pfizer’s consumer health business in March, it got another opportunity to team up on a deal. The two Big Pharma companies have de2018/12/20
-
Lilly's Taltz beats out AbbVie's megadrug Humira in psoriatic arthritis showdownWhat’s a surefire way to get noticed in any field? Beat out a behemoth. And that’s what Eli Lilly’s Taltz has just done in psoriatic arthritis (PsA). Monday, the Indianapolis drugmaker said its anti-2018/12/19
-
Mallinckrodt spinoff to include 7 manufacturing sites in U.S. and JapanWith its plan for a spinoff into two companies, Mallinckrodt will create an API and generics operation with a large controlled substances and acetaminophen business and seven manufacturing facilities2018/12/19
-
Astellas buys Potenza Therapeutics for up to $405mJapanese pharmaceutical company Astellas Pharma has acquired US-based Potenza Therapeutics for a total consideration of up to $405m. The deal is made possible as Astellas exercised its option to buy2018/12/18
-
AbbVie licences BioArctic’s Parkinson’s disease portfolioSwedish biopharma company BioArctic has secured clearance from US Federal Trade Commission (FTC) to out-licence its alpha-synuclein antibody portfolio to AbbVie. The portfolio is intended for the tre2018/12/18
-
Merck looks past Sanofi's dengue woes in development deal with Brazilian vaccine instituteEven after Sanofi suffered a costly dengue vaccine controversy last year, fellow pharma giant Merck & Co. isn’t backing away from the field. Instead, it hasstrucka new partnership with Brazil’s Bu2018/12/17
-
AstraZeneca mines for positives in Imfinzi's failed Mystic lung cancer trialAstraZeneca felt the blow last month whenMystic, a key trial examining its immuno-oncology drug Imfinzi in previously untreated lung cancer, failed. But now that the dust has settled, the company is l2018/12/17
-
Lilly teams up with AC Immune for Alzheimer’s drugEli Lilly has signed a licence and collaboration agreement with Swiss biotech AC Immune for the research and development of tau aggregation inhibitor small molecules to treat neurodegenerative disorde2018/12/14
-
NIH to support HIV care and prevention research in the USThe National Institute of Allergy and Infectious Diseases (NIAID), a National Institutes of Health (NIH) division, has announced plans to fund human immunodeficiency virus (HIV) care and prevention re2018/12/14
-
Pfizer still unable to get on top of problems at Hospira injectables plantSince Pfizer’s Kansas plant received an FDA warning letter last year, the company has insisted it is making good progress on turning things around at the essential but troubled injectables facility. B2018/12/13